A method of treating a patient having a HCV infection which method
comprises administering to said patient a cyclosporin A or a cyclosporin
A derivative in association with a conjugate of interferon to a
water-soluble polymer in an amount effective to alleviate or eliminate
one or more of the signs or symptoms of HCV.